The EASE-IT CT Registry

NCT05750173 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-06-15

No results posted yet for this study

Summary

ICA is not always required for a pre-TAVI workup of octogenarians and can be substituted by CTA resulting in a streamlined pre-procedural workup of patients without compromising patient safety.

Conditions

  • Transcatheter Aortic Valve Implantation (TAVI)

Interventions

OTHER

Streamlining of the pre-procedural patient pathway

Pre-TAVI ICA is associated with procedural risk, radiation, costs and requires hospitalization (2d). Show that CTA is a viable alternative to rule out ≥50% left main coronary artery (LM) / prox. left anterior descending artery (LAD) stenosis. An implementation of a standardized patient pathway which is reproducible, will help to streamline the pre-procedural workup of patients without compromising patient safety.

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY
  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Julia Mascherbauer, Prof. Dr. · Clinical Department for Internal Medicine 3, University Hospital St. Pölten, Austria

Eligibility

Min Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Austria
  • Germany

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05750173 on ClinicalTrials.gov